Filiz Ekici

Filiz Ekici

Auto-generated profile, based on publicly available information

Filiz Ekici

Akdeniz Üniversitesi Tıp Fakültesi, Pediatrik Kardiyoloji Bilim Dalı, Antalya, Türkiye

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2014 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
MGMehmet Gündüz
Mehmet Gündüz
FEFiliz Ekici
Filiz Ekici
EÖEda Özaydın
Eda Özaydın
SCSerdar Ceylaner
Serdar Ceylaner
BPBelen Perez
Belen Perez

14 February 2014 in Echocardiography
Verified
Journal Article
Closed access
PDF file
FEFiliz Ekici
Filiz Ekici
BVBirgül Varan
Birgül Varan
AKAbdullah Kocabaş
Abdullah Kocabaş
İEİlkay Erdoğan
İlkay Erdoğan
SESancar Eminoğlu
Sancar Eminoğlu
DADoğukan Aktaş
Doğukan Aktaş

16 June 2014 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
PDF file
IÇİbrahim İlker Çetin
İbrahim İlker Çetin
FEFiliz Ekici
Filiz Ekici
SÜSevim Ünal
Sevim Ünal
AKAbdullah Kocabaş
Abdullah Kocabaş
ŞŞŞanlıay Şahin
Şanlıay Şahin
GAGanime Ayar
Ganime Ayar
The medical records of 16 patients diagnosed as intracardiac thrombus were searched. The size, location and outcome of thrombus together with demographic data of patients were assessed. The median age of the patients was 2.2 years. Six patients were newborn and two patients were infant. The median size of thrombus was 9 mm. The localization was right atrium in seven, right ventricle in five, left ventricle in one, pulmonary artery in one, and superior vena cava in two patients. There was prematurity in five, ciyanotic congenital heart disease in one, blood culture positivity in three, malignancy in four, nephrotic syndrome in one, indwelling catheters in 10, and acquired or genetic thrombophilia in six patients as risk factors. In the treatment, the first choice was tissue plasminogen activator in two patients, heparin infusion in one patient and low molecular weight heparin in remaining 12 patients. In nine patients, therapy included parenteral antimicrobials together with anticoagulants. The result was complete resolution in 15 patients and in one patient thrombus was surgically removed. The median time was 16 (2–70) days for 50% resolution and 26 (3–93) days for complete resolution. There was a statistically significant (P = .027 and r = 0.5) correlation between the size and the complete resolution time. There was no anticoagulant therapy related major complication. In patients with intracardiac thrombus, selection of anticoagulant therapy may decrease the risk of complications. Surgery is rarely required and thrombolytics are not usually necessary for resolution of thrombus.

22 August 2017 in Echocardiography
Verified
Journal Article
Closed access
PDF file
FEFiliz Ekici
Filiz Ekici
DUDiyar Uslu
Diyar Uslu
SBSelen Bozkurt
Selen Bozkurt

1 September 2023 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
MBMuhammet Bulut
Muhammet Bulut
FEFiliz Ekici
Filiz Ekici
TTTuğce Tural-Kara
Tuğce Tural-Kara
NTNazan Ulgen Tekerek
Nazan Ulgen Tekerek
SASenay Akbay
Senay Akbay
FKFirat Kardelen
Firat Kardelen
Cardiovascular involvement,COVID-19,outcomes,pediatric multi-inflammatory syndrome

20 July 2012 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
FEFiliz Ekici
Filiz Ekici
NÇNilgün Çakar
Nilgün Çakar
Intracardiac thrombus is a rare complication of nephrotic syndrome in children, and only a few cases have been reported. We report the case of a 3.5-year-old child diagnosed with Henoch–Schönlein Purpura and steroid-resistant nephrotic syndrome for 2 months. The patient had massive oedema but no cardiovascular instability. Echocardiography displayed a large thrombus within the right atrium and the patient was successfully managed with enoxoparine.